Clinical Trial Update: Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets [Phase 4]

View source ↗

Summary

Phase 4 trial update exploring GLP-1 agonism combined with very low calorie diets in obese individuals with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus in Obese

Snippet

Sponsor: University of Nottingham | Conditions: Type 2 Diabetes Mellitus in Obese | Phase 4 | Status: UNKNOWN